References: Vaira LA, Deiana G, Fois AG, et al. Objective evaluation of anosmia and ageusia in COVID-19 patients: single-center experience on 72 cases. Head Neck. 2020;42:1252-1258.
Boscolo-Rizzo P, Guida F, Polesel J, et al. Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19). Int Forum Allergy Rhinol. 9, 2021.
Walker A, Kelly C, Pottinger G, et al. Parosmia-a common consequence of covid-19. BMJ. 2022;377:e069860.
Parker JK, Kelly CE, Gane SB. Insights into the molecular triggers of parosmia based on gas chromatography olfactometry. Commun Med. 2022;2:1-8.
Liu DT, Welge-Lussen A, Besser G, Mueller CA, Renner B. Assessment of odor hedonic perception: the Sniffin'sticks parosmia test (SSParoT). Sci Rep. 2020;22:18019.
Reden J, Maroldt H, Fritz A, et al. A study on the prognostic significance of qualitative olfactory dysfunction. Head Neck Surg. 2007;264:139-144.
Landis BN, Frasnelli J, Croy I, et al. Evaluating the clinical usefulness of structured questions in parosmia assessment. Laryngoscope. 2010;120:1707-1713.
Boscolo-Rizzo P, Hummel T, Hopkins C, et al. High prevalence of long-term olfactory, gustatory, and chemesthesis dysfunction in post-COVID-19 patients: a matched case-control study with one-year follow-up using a comprehensive psychophysical evaluation. Rhinology. 2021;59:517-527.
Vaira LA, Gessa C, Deiana G, et al. The effects of persistent olfactory and gustatory dysfunctions on quality of life in long-COVID-19 patients. Life. 2022;12:141.
No Comments.